IP Library Granted Patent US 12,698,264
Granted Patent B2
US 12,698,264 · App. 18/264,939 · Granted Aug 4, 2026

Synthesis of tigilanol tiglate and analogs thereof

Inventors: Paul A. Wender (Menlo Park, CA); Nguyen Hong Quang Luu (Menlo Park, CA); Zachary Gentry (Palo Alto, CA); Edward Njoo (Freemont, CA); David Fanelli (Stanford, CA); Owen Dennis McAteer (Stanford, CA)
Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
C07D303/14A61K31/122A61K36/47A61K2236/15A61K2236/33A61K2236/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,698,264
App. No.
18/264,939
Filed
Aug 10, 2023
Granted
Aug 4, 2026
Kind
B2
Art Unit
1625
USPC
549/523
Abstract

Provided are methods for the isolation of phorbol from seed sources and the use of the phorbol for the generation of tigliane tiglate and derivatives thereof.

Claims (12)

1 . A method for the synthesis of tigilanol tiglate, precursors, and analogs thereof, the method comprising the steps as shown in the schema shown in FIG. 3 of the disclosure.

2 . A method for the synthesis of tigilanol tiglate, the method comprising the steps as shown in the schema shown in FIG. 3 of the disclosure.

3 . A method of isolating Phorbol (2) from Croton tiglium seeds, the method comprising the steps of:

(a) pulverizing Croton tiglium seeds;

(b) extracting the pulverized seeds by refluxing with methanol and concentrating the product thereof to an oil;

(c) extracting the oil with a plurality of methanol washes and pooling the methanol washes;

(d) adding cesium carbonate to the methanol washes with prolonged stirring

(e) acidifying the product of the preceding step with 6M sulfuric acid to a pH of 5.5;

(f) filtering the acidified product and concentrating the filtrate therefrom under reduced pressure at 30° C.;

(g) saturating the aqueous suspension from step (f) sodium chloride;

(h) washing the aqueous phase with diethyl ether;

(i) extracting the diethyl ether with tetrahydrofuran (THF) and concentrating the THF extract under reduced pressure at 30° C.; drying the THF extract concentrate and purifying by silica gel vacuum column chromatography.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2023
From: WENDER, PAUL A.; LUU, NGUYEN HONG QUANG; GENTRY, ZACHARY; NJOO, EDWARD; FANELLI, DAVID; MCATEER, OWEN DENNIS
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 065469/0145 →
Continuity (2)
Provisional Application 63159163 · Mar 10, 2021
Related Publication 20240132460A1 · Apr 25, 2024
References Cited (80)
US 9770431B2 · Reddell et al. · 2017 [cited by applicant]
US 10183921B2 · Reddell et al. · 2019 [cited by applicant]
US 20160158187A1 · Reddell et al. · 2016 [cited by applicant]
US 20160280627A1 · Hogberg et al. · 2016 [cited by applicant]
EP 1939192A1 · 2008 [cited by examiner]
WO 2007070985A1 · 2007 [cited by applicant]
WO WO2008010831A1 · 2008 [cited by examiner]
Zhang, Feng, et al., “CRISPR/Cas9 for genome editing: progress, implications and challenges,” Human Molecular Genetics, vol. 23 (2014), pp. R40-R46. [cited by applicant]
Yin, Gang, et al., “Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system,” mAbs, vol. 4, No. 2 (2012), pp. 217-225. [cited by applicant]
Winter, Greg, et al., “Man-made antibodies,” Nature, vol. 349 (1991), pp. 293-299. [cited by applicant]
Taylor, P.R., et al., “Macrophage Receptors and Immune Recognition,” Annu. Rev. Immunol., vol. 23 (2005), pp. 901-944. [cited by applicant]
Steinberger, Peter, et al., “Generation and Characterization of a Recombinant Human CCR5-specific Antibody,” J. Biol. Chem., vol. 275, No. 46 (2000), pp. 36073-36078. [cited by applicant]
Schenk, Mirjam, et al., “TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases,” J. Clin. Invest., vol. 117 (2007), pp. 3097-3106. [cited by applicant]
Riechmann, Lutz, et al., “Reshaping human antibodies for therapy,” Nature, vol. 332 (1988), pp. 323-329. [cited by applicant]
Radar, Christoph, et al., “A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries,” Proc. Nat. Acad. Sci. U.S.A., vol. 95 (1998), pp. 8910-8915. [cited by applicant]
Queen, Cary, et al., “A humanized antibody that binds to the interleukin 2 receptor,” Proc. Natl. Acad. Sci. U.S.A., vol. 86 (1989), pp. 10029-10033. [cited by applicant]
Presta, Leonard, “Antibody engineering,” Current Opinion in Biotechnology, vol. 3 (1992), pp. 593-596. [cited by applicant]
Poukoulidou, Thekla, et al., “TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen,” BMC Infectious Diseases, vol. 11 (2011) (8 pages). [cited by applicant]
Oakley, Holly, et al., “Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation,” The … [cited by applicant]
Nathan, Carl, et al., “TREM-1: A new regulator of innate immunity in sepsis syndrome,” Nat. Med., vol. 7 (2001), pp. 530-532. [cited by applicant]
Marks, James D., et al., “By-passing Immunization: Human Antibodies from V-gene Libraries Displayed on Phage,” J. Mol. Biol., vol. 222 (1991), pp. 581-597. [cited by applicant]
Maccallum, Robert M., et al., “Antibody-antigen Interactions: Contact Analysis and Binding Site Topography,” J. Mol. Biol., vol. 272 (1996), pp. 732-745. [cited by applicant]
Liu, Qingkun, et al., “Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity,” Nat. Immunol., vol. 20, No. 8 (2019), pp. 1023-1034. [cited by applicant]
Lefranc, Marie-Paule, et al., “IMGT unique numbering for immunoglobulin and T cell receptor variable domains and IG superfamily V-like domains,” Developmental and Comparative Immunology, vol. 27 (2003), pp. 55-77. [cited by applicant]
Kozbor, D., et al., “A human hybrid myeloma for production of human monoclonal antibodies,” The Journal of Immunology, vol. 133, No. 6 (1984), pp. 3001-3005. [cited by applicant]
Köhler, G., et al. “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature, vol. 256 (1975), pp. 495-497. [cited by applicant]
Jones, Peter T., et al. “Replacing the complementarity-determining regions in a human antibody with those from a mouse,” Nature, vol. 321 (1986), pp. 522-525. [cited by applicant]
Jankowsky, Joanna L., et al. “Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase,” Human Molecular Genetics, vol. 13, N… [cited by applicant]
International Search Report and Written Opinion, PCT Application No. PCT/US2022/019718, mailed Jul. 5, 2022. [cited by applicant]
Ahmed, Waled Abdo, et al., “Phorbol Ester as Toxic Constituents of Tropical Jatropha Curcas Seed Oil,” European Journal of Scientific Research, vol. 31, No. 3 (2009), pp. 429-436. [cited by applicant]
Wender, Paul A., et al., “The First Formal Asymmetric Synthesis of Phorbol,” Journal of American Chemical Soc., vol. 119 (1997), p. 7897. [cited by applicant]
Johnson, D. E.; Burtness, B.; Leemans, C. R.; Lui, V. W.Y.; Bauman, J. E.; Grandis, J. R. Head and Neck Squamous Cell Carcinoma. Nat. Rev. Dis. Prim. 2020, 6 (1) DOI: 10.1038/s41572-020-00224-3. [cited by applicant]
Osazuwa-Peters, N.; Simpson, M. C.; Zhao, L.; Boakye, E. A.; Olomukoro, S. I.; Deshields, T.; Loux, T. M.; Varvares, M. A.; Schootman, M. Suicide Risk among Cancer Survivors: Head and Neck versus Other Cancers. Cancer 2… [cited by applicant]
Barnett, C. M. E.; Broit, N.; Yap, P. Y.; Cullen, J. K.; Parsons, P. G.; Panizza, B. J.; Boyle, G. M. Optimising Intratumoral Treatment of Head and Neck Squamous Cell Carcinoma Models with the Diterpene Ester Tigilanol … [cited by applicant]
Panizza, B. J.; de Souza, P.; Cooper, A.; Roohullah, A.; Karapetis, C. S.; Lickliter, J. D. Phase I Dose-Escalation Study to Determine the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of an Intratumor… [cited by applicant]
Boyle, G. M.; D'Souza, M. M. A.; Pierce, C. J.; Adams, R. A.; Cantor, A. S.; Johns, J. P.; Maslovskaya, L.; Gordon, V. A.; Reddell, P. W.; Parsons, P. G. Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidl… [cited by applicant]
Moses, R. L.; Boyle, G. M.; Howard-Jones, R. A.; Errington, R. J.; Johns, J. P.; Gordon, V.; Reddell, P.; Steadman, R.; Moseley, R. Novel Epoxy-Tiglianes Stimulate Skin Keratinocyte Wound Healing Responses and Re-Epithe… [cited by applicant]
Lamont, R. W.; Conroy, G. C.; Reddell, P.; Ogbourne, S. M. Population Genetic Analysis of a Medicinally Significant Australian Rainforest Tree, Fontainea Picrosperma C.T. White (Euphorbiaceae): Biogeographic Patterns an… [cited by applicant]
Grant, E. L.; Wallace, H. M.; Trueman, S. J.; Reddell, P. W.; Ogbourne, S. M. Floral and Reproductive Biology of the Medicinally Significant Rainforest Tree, Fontainea Picrosperma (Euphorbiaceae). Ind. Crops Prod. 2017,… [cited by applicant]
Grant, E. L.; Conroy, G. C.; Lamont, R. W.; Reddell, P. W.; Wallace, H. M.; Ogbourne, S. M. Short Distance Pollen Dispersal and Low Genetic Diversity in a Subcanopy Tropical Rainforest Tree, Fontainea Picrosperma (Eupho… [cited by applicant]
Godfree, R. C.; Knerr, N.; Godfree, D.; Busby, J.; Robertson, B.; Encinas-Viso, F. Historical Reconstruction Unveils the Risk of Mass Mortality and Ecosystem Collapse during Pancontinental Megadrought. Proc. Natl. Acad.… [cited by applicant]
Honnay, O.; Jacquemyn, H. Susceptibility of Common and Rare Plant Species to the Genetic Consequences of Habitat Fragmentation. Conserv. Biol. 2007, 21 (3), 823-831 DOI: 10.1111/j.1523-1739.2006.00646.x. [cited by applicant]
Newman, D. J.; Cragg, G. M. Natural Products as Sources of New Drugs from 1981 to 2014. 2016 DOI: 10.1021/acs.jnatprod.5b01055. [cited by applicant]
Goel, G.; Makkar, H. P. S.; Francis, G.; Becker, K. Phorbol Esters: Structure, Biological Activity, and Toxicity in Animals. Int. J. Toxicol. 2007, 26 (4), 279-288 DOI: 10.1080/10915810701464641. [cited by applicant]
Ryves, W. J.; Evans, A. T.; Olivier, A. R.; Parker, P. J.; Evans, F. J. Activation of the PKC-Isotypes Alpha, Beta 1, Gamma, Delta and Epsilon by Phorbol Esters of Different Biological Activities. FEBS Lett. 1991, 288 (… [cited by applicant]
Beans, E. J.; Fournogerakis, D.; Gauntlett, C.; Heumann, L. V; Kramer, R.; Marsden, M. D.; Murray, D.; Chun, T.-W.; Zack, J. A.; Wender, P. A. Highly Potent, Synthetically Accessible Prostratin Analogs Induce Latent HIV… [cited by applicant]
Wender, P. A.; Debrabander, J.; Harran, P. G.; Jimenez, J.-M.; Koehler, M. F. T.; Lippa, B.; Park, C.-M.; Siedenbiedel, C.; Pettit, G. R. The Design, Computer Modeling, Solution Structure, and Biological Evaluation of S… [cited by applicant]
Wender, P. A.; Koehler, K. F.; Sharkey, N. A.; Dell'Aquila, M. L.; Blumberg, P. M. Analysis of the Phorbol Ester Pharmacophore on Protein Kinase C as a Guide to the Rational Design of New Classes of Analogs (Tumor Promo… [cited by applicant]
Wender, P. a; Kee, J.-M.; Warrington, J. M. Practical Synthesis of Prostratin, DPP, and Their Analogs, Adjuvant Leads against Latent HIV. Science 2008, 320 (5876), 649-652 DOI: 10.1126/science.1154690. [cited by applicant]
Pagani, A.; Gaeta, S.; Savchenko, A. I.; Williams, C. M.; Appendino, G. An Improved Preparation of Phorbol from Croton Oil. Beilstein J. Org. Chem. 2017, 13, 1361-1367 DOI: 10.3762/bjoc.13.133. [cited by applicant]
Schmidt, R.; Hecker, E. Autoxidation of Phorbol Esters under Normal Storage Conditions. Cancer Res. 1975, 35 (5), 1375-1377. [cited by applicant]
Evans, D. A.; Chapman, K. T. The Directed Reduction of B-Hydroxy Ketones Employing Me4NHB(OAc)3. Tetrahedron Lett. 1986, 27 (49), 5939-5942 DOI: 10.1016/S0040-4039(00)85367-8. [cited by applicant]
Jin, Y.; Shi, L.; Zhang, D.; Wei, H.; Si, Y.; Ma, G. A Review on Daphnane-Type Diterpenoids and Their Bioactive Studies. Molecules 2019, 24 (1842), 1-14. [cited by applicant]
Hanson, R. M. Epoxide Migration (Payne Rearrangement) and Related Reactions. Org. React. 2004, 1-156. [cited by applicant]
Wender, P. A.; Buschmann, N.; Cardin, N. B.; Jones, L. R.; Kan, C.; Kee, J.-M.; Kowalski, J. A.; Longcore, K. E. Gateway Synthesis of Daphnane Congeners and Their Protein Kinase C Affinities and Cell-Growth Activities. … [cited by applicant]
Ghogare, A. A.; Greer, A. Using Singlet Oxygen to Synthesize Natural Products and Drugs. Chem. Rev. 2016, 116 (17), 9994-10034 DOI: 10.1021/acs.chemrev.5b00726. [cited by applicant]
Gupta, V. K.; Mittal, A.; Jhare, D.; Mittal, J. Batch and Bulk Removal of Hazardous Colouring Agent Rose Bengal by Adsorption Techniques Using Bottom Ash as Adsorbent. RSC Adv. 2012, 2 (22), 8381-8389 DOI: 10.1039/c2ra2… [cited by applicant]
Boudreault, P. L.; Mattler, J. K.; Wender, P. A. Studies on the Regio- and Diastereo-Selective Epoxidation of Daphnanes and Tiglianes. Tetrahedron Lett. 2015, 56 (23), 3423-3427 DOI: 10.1016/j.tetlet.2015.01.126. [cited by applicant]
Simone, G. Tigliane Diterpenoids: Isolation, Chemistry and Preliminary Biosynthetic Studies of a Medicinal Relevant Class of Natural Compounds, Universita Del Piemonte Orientale, 2019. [cited by applicant]
Newton, A. C. & Brognard, J. Reversing the paradigm: protein kinase C as a tumor suppressor. Trends Pharmacol. Sci. 38, 438-447 (2017). [cited by applicant]
Kim, J. T. et al. Latency reversal plus natural killer cells diminish HIV reservoir in vivo. Nat. Commun. 13, 121 (2022). [cited by applicant]
Ramakrishna, S. et al. Modulation of target antigen density improves CAR T-cell functionality and persistence. Clin. Cancer Res. 25, 5329-5341 (2019). [cited by applicant]
Hardman, C. et al. Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy. Nat. Commun. 11, 1-11 (2020). [cited by applicant]
Marro, B. S. et al. Discovery of small molecules for the reversal of T-cell exhaustion. Cell Rep. 29, 3293-3302 (2019). [cited by applicant]
Farlow, M. R. et al. A randomized, double-blind, placebo-controlled, phase II study assessing safety, tolerability, and efficacy of bryostatin in the treatment of moderately severe to severe Alzheimer's disease. J. Alzh… [cited by applicant]
Cullen, J. K. et al. Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes. Sci Rep. 11, 1-14 (2021). [cited by applicant]
Miller, J. et al. Dose characterization of the investigational anticancer drug tigilanol tiglate (EBC-46) in the local treatment of canine mast cell tumors. Front. Vet. Sci. 6, 1-10 (2019). [cited by applicant]
FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs https://www.fda.gov/news-events/press-announcements/fda-approves-first-intratumoral-injection-treat-non-metastatic-mast-cell-tum… [cited by applicant]
De Ridder, T. R. et al. Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46). J. Vet. Intern. Med. 35, 415-429 (202… [cited by applicant]
Grant, E. L. et al. Floral attraction and flower visitors of a subcanopy, tropical rainforest tree, Fontainea Picrosperma. Ecol. Evol. 11, 10468-10482 (2021). [cited by applicant]
Grant, E. Reproductive Biology, Flowering and Genetics of Fontainea picrosperma (Euphorbiaceae). PhD thesis, Univ. Sunshine Coast (2020). [cited by applicant]
Wender, P. A., Quiroz, R. V. & Stevens, M. C. Function through synthesis-informed design. Acc. Chem. Res. 48, 752- 760 (2015). [cited by applicant]
Kim, K. E., Kim, A. N., McCormick, C. J. & Stoltz, B. M. Late-stage diversification: a motivating force in organic synthesis. J. Am. Chem. Soc. 143, 16890-16901 (2021). [cited by applicant]
Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from Jan. 1981 to Sep. 2019. J. Nat. Prod. 83, 770-803 (2020). [cited by applicant]
Kawamura, S., Chu, H., Felding, J. & Baran, P. S. Nineteen-step total synthesis of (+)-phorbol. Nature 532, 90-93 (2016). [cited by applicant]
Ahmed, W. A. & Salimon, J. Phorbol ester as toxic constituents of tropical Jatropha curcas seed oil. Eur. J. Sci. Res. 31, 429-436 (2009). [cited by applicant]
Hou, Z., Yao, G. & Song, S. Daphnane-type diterpenes from genus Daphne and their anti-tumor activity. Chin. Herbal Medicines 13, 145-156 (2021). [cited by applicant]
Zhang, G., Kazanietz, M. G., Blumberg, P. M. & Hurley, J. H. Crystal structure of the Cys2 activator-binding domain of protein kinase Co in complex with phorbol ester. Cell 81, 917-924 (1995). [cited by applicant]
Sagadevan, A., Hwang, K. C. & Su, M.-D. Singlet oxygen-mediated selective C-H bond hydroperoxidation of ethereal hydrocarbons. Nat. Commun. 8, 1812 (2017). [cited by applicant]
Benner, N. L. et al. Functional DNA delivery enabled by lipid-modified charge-altering releasable transporters (CARTs). Biomacromolecules 19, 2812-2824 (2018). [cited by applicant]